Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulmatrix (PULM) EBIT Margin (2016 - 2024)

Pulmatrix's EBIT Margin history spans 10 years, with the latest figure at 65066.67% for Q4 2024.

  • For Q4 2024, EBIT Margin fell 6496562.0% year-over-year to 65066.67%; the TTM value through Sep 2025 reached 207100.0%, down 20699969.0%, while the annual FY2024 figure was 125.07%, 7690.0% up from the prior year.
  • EBIT Margin for Q4 2024 was 65066.67% at Pulmatrix, down from 725.96% in the prior quarter.
  • Across five years, EBIT Margin topped out at 12.69% in Q1 2024 and bottomed at 65066.67% in Q4 2024.
  • The 5-year median for EBIT Margin is 262.83% (2022), against an average of 3539.48%.
  • The largest annual shift saw EBIT Margin skyrocketed 63340bps in 2022 before it tumbled -6496562bps in 2024.
  • A 5-year view of EBIT Margin shows it stood at 133.7% in 2020, then tumbled by -563bps to 886.62% in 2021, then soared by 71bps to 253.22% in 2022, then surged by 60bps to 101.04% in 2023, then tumbled by -64294bps to 65066.67% in 2024.
  • Per Business Quant, the three most recent readings for PULM's EBIT Margin are 65066.67% (Q4 2024), 725.96% (Q3 2024), and 380.22% (Q2 2024).